Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire, Rosetta Integrate Platforms

NEW YORK, May 28 - Spotfire and Rosetta Biosoftware said today they will integrate their DecisionSite and Resolver technologies.

 

Under the three-year deal, current and future customers who subscribe to the platforms will be able to use both products simultaneously.

The integration will be available as early as July at no additional cost to customers who use both tools. It will take place either over the Internet or through an installation process, said David Butler, vice president of product strategy and marketing at Spotfire.

 

Click here for more information.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.